Written answers
Tuesday, 20 November 2018
Department of Health
Rare Diseases
James Browne (Wexford, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
416. To ask the Minister for Health the number of times the rare disease technology review committee has met; the name of each member; and if he will make a statement on the matter. [47996/18]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
James Browne (Wexford, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
417. To ask the Minister for Health the number of drugs considered by the rare disease technology review committee; the names of the drugs; and if he will make a statement on the matter. [47997/18]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments